Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy.
Lu YC, Chuang CH, Chuang KH, Chen IJ, Huang BC, Lee WH, Wang HE, Li JJ, Cheng YA, Cheng KW, Wang JY, Hsieh YC, Lin WW, Cheng TL.
Lu YC, et al.
PLoS Biol. 2019 Jun 13;17(6):e3000286. doi: 10.1371/journal.pbio.3000286. eCollection 2019 Jun.
PLoS Biol. 2019.
PMID: 31194726
Free PMC article.